Recent clinical trial results in pancreatic and rectal cancers are challenging long-standing treatment norms, showing unprecedented survival gains and organ preservation potential. Innovations include ...
The indie action RPG The Awakener: Battle Tendency is built around a clear design philosophy that prioritizes combat, loot, ...
3don MSNOpinion
Contributor: Drug courts fail women, but there's a solution
These courts in L.A. and elsewhere operate on models built around male patterns of addiction and accountability. Hawaii tried ...
Treatment with the investigational next-generation KRAS-G12C inhibitor elisrasib led to clinical benefit in patients with ...
Seasoned Biopharma leader bringing deep commercial experience to shape and inform corporate strategy, clinical trial design ...
Recent studies have suggested that sugar substitutes might not be the free lunch they're advertised as. We asked experts what ...
Boston Scientific (NYSE:BSX) today shared new clinical findings supporting its wide-ranging electrophysiology (EP) portfolio.
Chimeric antigen receptor T-cell therapy conferred sustained benefit to individuals with high-risk smoldering multiple myeloma, according to phase 2 trial results. All patients who received a single ...
Pivotal Phase 3 NOVA-2 trial in schizophrenia ongoing, topline data expected in 2H 2027LB-102 has potential to be the first benzamide approved ...
Definium Therapeutics, Inc. (Nasdaq: DFTX) (“Definium” or the “Company”), a late-stage clinical biopharmaceutical company developing a new generation of therapeutics intended to address the underlying ...
De Novo FDA submission for moderate-to-severe insomnia HOUSTON, TX, April 22, 2026 (GLOBE NEWSWIRE)-- Nexalin Technology, Inc. (Nasdaq: NXL) (the “Company” or “Nexalin”), the leader in non-invasive ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results